Rescue therapy with tacrolimus after combined kidney/pancreas and isolated pancreas transplantation in patients with severe cyclosporine nephrotoxicity

Transplantation

Volumn 61, Issue 8, 1996, Pages 1161-1165

  Hariharan, Sundaram ^a,c   Munda, Rino ^a   Cavallo, Tito ^a   Demmy, Ann M ^b   Schroeder, Timothy J ^a   Alexander, J Wesley ^a   First, M Roy ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

^c FROEDTERT MEMORIAL LUTHERAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; CYCLOSPORIN; GLUCOSE; HEMOGLOBIN A1C; METHYLPREDNISOLONE; OKT 3; TACROLIMUS;

ADULT; ARTICLE; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; GRAFT REJECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY TRANSPLANTATION; MALE; NEPHROTOXICITY; ORAL DRUG ADMINISTRATION; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; VASCULAR DISEASE;

ADMINISTRATION, ORAL; ADULT; CYCLOSPORINE; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PANCREAS TRANSPLANTATION; TACROLIMUS;

EID: 0030007825     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199604270-00007     Document Type: Article

References (20)

1. Sollinger HW, Knechtle SJ, Reed A, et al. Experience with 100 consecutive simultaneous kidney-pancreas transplants with bladder drainage. Ann Surg 1991; 214: 703.
2. Sollinger HW, Kalayoglu M, Hoffmann RM, Deierhoi MH, Belzer FO. Experience with pancreaticocystostomy in 24 consecutive pancreas transplants. Transplant Proc 1985; 17 (suppl 2): 141.
3. D'Alessandro AM, Stratta RJ, Sollinger HW, Kalayoglu M, Pirsch JD, Belzer FO. Use of UW solution in pancreas transplantation. Diabetes 1989; 38: 7.
4. Sutherland DER. State of the art in pancreas transplantation. Transplant Proc 1994; 26: 316.
5. Rosen CB, Frohnert PP, Velosa JA, Engen DE, Steriooff S. Morbidity of pancreas transplantation during cadaveric renal transplantation. Transplantation 1991; 51: 123.
6. Shaffer D, Madras PN, Sahyoun AI, et al. Combined kidney and pancreas transplantation: a 3 year experience. Arch Surg 1992; 127: 574.
7. Thiel G, Bock A, Spondlions M, et al. Long-term benefits and risks of cyclosporin A (Sandimmune) - an analysis at 10 years. Transplant Proc 1994; 26: 2493.
8. First MR, Smith RD, Weiss MA, et al. Cyclosporine-associated glomerular and arteriolar thrombosis following renal transplantation. Transplant Proc 1989; 21: 1567.
9. U.S. Multicenter FK506 liver study group. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 1994; 331: 1110.
10. European FK506 Multicentre liver study group: Randomized trial comparing tacrolimus (FK506) and cyclosporine in prevention of liver allograft rejection. Lancet 1994; 344: 423.
11. Shapiro R, Jordan M, Scantlebury V, et al. A prospective, randomized trial of FK506 in renal transplantation - a comparison between double- and triple-drug therapy. Clin Transplant 1994; 8: 508.
12. Shapiro R, Jordan M, Fung JJ, et al. Kidney transplantation under FK506 immunosuppression. Transplant Proc 1991; 23: 920.
13. Starzl TE, Fung J, Venkatramanan R, Todo S, Demetris A, Jain A. FK506 for liver, kidney and pancreas transplantation. Lancet 1989; 2: 1000.
14. Lewis WB, Jenkins RL, Burke PA, et al. FK506 rescue therapy in liver transplant recipients with drug resistant rejection. Transplant Proc 1991; 23: 2989.
15. Klintmalm GBG, Goldstein R, Gonwa T, et al. U.S. multicenter FK506 study group. Use of prograf (FK506) as rescue therapy for refractory rejection after liver transplantation. Transplant Proc 1993; 25: 679.
16. Jordan ML, Shapiro R, Vivas CA, et al. FK506 salvage of renal allgrafts with ongoing rejection failing cyclosporine immunosuppression. Transplant Proc 1993; 25: 638.
17. Jordan ML, Shapiro R, Vivas CA, et al. FK506 rescue for resistant rejection of renal allografts under primary cyclosporine immunosuppression. Transplantation 1994; 57: 860.
18. Scantlebury V, Shapiro R, Fung J, et al. New onset of diabetes in FK506 vs cyclosporine-treated kidney transplant recipients. Transplant Proc 1991; 23: 3169.
19. Terasaki S, Babazona T, Koike T, et al. Effect of rescue therapy using FK506 on relapsing rejection after combined pancreas and kidney transplantation. Transplant Proc 1995; 27: 1335.
20. Shaffer D, Simpson MA, Conway P, Madras PN, Monaco AP. Normal pancreas allograft function following simultaneous pancreas kidney transplantation after rescue therapy with tacrolimus (FK506). Transplantation 1995; 59: 1063.